Erlotinib - PDFSEARCH.IO - Document Search Engine

Erlotinib
Results: 189

#	Item
51	AstraZeneca submission to the Post-Market Review of Authority Required PBS listings AstraZeneca welcomes the opportunity to contribute to the Post-Market Review of Authority Required Pharmaceutical Benefits Schedule (PBS Add to Reading List Source URL: pbs.gov.au Language: English - Date: 2015-03-02 18:33:44 Quinazolines Organofluorides Amines Organochlorides Pharmaceutical Benefits Scheme Protein kinase inhibitor Quality use of medicines Gefitinib Erlotinib Chemistry Organic chemistry AstraZeneca
52	The HDAC inhibitor, MPT0E028, enhances erlotinib-induced cell death in EGFR-TKI-resistant NSCLC cells Add to Reading List Source URL: www.nature.com Language: English - Date: 2013-09-19 09:55:19 Quinazolines Amines Tyrosine kinase receptors Lung cancer Organofluorides Erlotinib Gefitinib Epidermal growth factor receptor Targeted therapy Chemistry Medicine Organic chemistry
53	Erlotinib derivative inhibits hepatocellular carcinoma by targeting CIP2A to reactivate protein phosphatase 2A Add to Reading List Source URL: www.nature.com Language: English - Date: 2014-07-31 08:37:39 Cell signaling KIAA1524 Apoptosis AKT Protein phosphatase 2 Hepatocellular carcinoma Targeted therapy Erlotinib Epidermal growth factor receptor Biology Chemistry Medicine
54	Microsoft Word - Figure 1 Orzaez CDDis Add to Reading List Source URL: www.nature.com Language: English - Date: 2012-10-25 05:59:49 Cell signaling Apoptosis Caspase 3 Erlotinib Targeted therapy Gefitinib Caspase Fas receptor Epidermal growth factor receptor Biology Cell biology Programmed cell death
55	OPEN Citation: Cell Death and Disease[removed], e1260; doi:[removed]cddis[removed] & 2014 Macmillan Publishers Limited All rights reserved[removed]www.nature.com/cddis Add to Reading List Source URL: www.nature.com Language: English - Date: 2014-05-29 08:44:58 Organic chemistry Non-small-cell lung carcinoma ERCC1 Gefitinib MicroRNA Epidermal growth factor receptor Erlotinib KRAS Cetuximab Chemistry Lung cancer Medicine
56	The HSP90 Inhibitor, AT13387, Displays Single Agent Activity in Erlotinib-Sensitive and -Resistant Models of EGFR-Activated NSCLC Keisha Hearn, Tomoko Smyth, Jon Lewis, Vanessa Martins, Neil Thompson, Mohammad Azab, John Add to Reading List Source URL: astx.com Language: English Amines Organofluorides Alkynes Organochlorides Gefitinib Erlotinib Epidermal growth factor receptor Hsp90 Protein kinase inhibitor Chemistry Organic chemistry Quinazolines
57	The HSP90 inhibitor, AT13387, combined with erlotinib improves response in EGFR-driven xenograft models of NSCLC[removed]Tomoko Smyth, Jon Lewis, Keisha Hearn, Aurélie Courtin, Neil Thompson, John Lyons, Nicola Wallis 1As Add to Reading List Source URL: astx.com Language: English - Date: 2014-06-09 09:13:18 Amines Lung cancer Alkynes Erlotinib Ethers Epidermal growth factor receptor Non-small-cell lung carcinoma Hsp90 Chemistry Organic chemistry Quinazolines
58	Microsoft PowerPoint - NWallis TAT O11-5 Final Add to Reading List Source URL: astx.com Language: English - Date: 2014-06-09 11:38:56 Organofluorides Piperidines Lung cancer Crizotinib Pyrazoles Protein kinase inhibitor Anaplastic lymphoma kinase Erlotinib Hsp90 Chemistry Organic chemistry Pfizer
59	November 2012 Volume 16, Issue 9 The investment report that gives you the essenƟals to wisely invest in biotechnology securiƟes. Add to Reading List Source URL: www.biotechnav.com Language: English - Date: 2013-01-16 17:13:33 Alkynes Amines Piperazines Organochlorides AP26113 Gefitinib Erlotinib Crizotinib Non-small-cell lung carcinoma Chemistry Organic chemistry Organofluorides
60	Lung Cancer Making Education Easy In this issue: HDREB for recurrent bronchial carcinoma Add to Reading List Source URL: www.altg.com.au Language: English - Date: 2012-06-25 05:35:25 Lung cancer Amines Quinazolines Alkynes Erlotinib Pfizer Gefitinib Bevacizumab Non-small-cell lung carcinoma Medicine Chemistry Oncology

UPDATE